HOME >> BIOLOGY >> NEWS
BioMed Central to free scientists and clinical researchers from copyright restrictions

Researchers will be free from the restrictive copyright agreements usually imposed by scientific journals thanks to a groundbreaking move announced by a new publishing house today. Authors publishing papers on BioMed Central will retain the copyright of their work, allowing them to freely distribute and archive their research findings however they see fit. All peer-reviewed research published by BioMed Central will also be made available immediately on PubMed Central, the NIH-sponsored repository for biological and medical research www.pubmedcentral.nih.gov, and on www.biomedcentral.com.

"BioMed Central promises to offer all primary research without financial and copyright barriers," says Professor Marc W Kirschner, Head of the Department of Cell Biology at Harvard Medical School. "This will allow scientists the freedom to participate in a truly worldwide community of scholars. It deserves all our support".

"We will make the publishing of original research quicker, easier and free to all," says Vitek Tracz, Chairman of BioMed Central. "Restrictive copyright agreements are simply not in keeping with our intention to help scientists communicate research findings as effectively as possible."

Current industry practice typically requires researchers to transfer the copyright of their work to the journal publisher. However, BioMed Central will require only the non-exclusive right to distribute the research and to be cited as the original publisher of the article. "We do not see primary research data as a direct source of income for us," continues Tracz, "We want to redefine the role of commercial biomedical publishing by focusing on adding value and offering services that complement the freely-available original research and literature of the future."

BioMed Central will, in addition to publishing primary research papers free-of-charge on the internet, provide commentary, reviews, news, alerting services, databases and e-commerce services. So
'"/>

Contact: Andrew McLaughlin or John Peel
andrew@biomedcentral.com or john@biomedcentral.com
44-0-20-7323-0323
BioMed Central
5-Apr-2000


Page: 1 2

Related biology news :

1. BioMed Central to consult funders and librarians over Open Access payment model
2. LA BioMed Medical/Research Briefs, July/August 2004
3. BioMed Central explodes Open Access myths
4. The Scientist and BioMed Central come together to publish high-impact magazine
5. BioMed Central is pleased to announce the publication of Sydney Brenners autobiography
6. BioMed Central to deposit e-journals with the British Library
7. BioMed Central to consider charging authors for paper submissions
8. Get Research on the move with BioMed Central
9. BioMed Central to launch at microbiology meeting
10. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
11. Sediments in many Central Valley streams contain toxic levels of pyrethroid pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/15/2019)... ... ... Deep Science Ventures (DSV), a new paradigm for applied science, today announced ... 100 companies over the next 10 years to address the urgent need for new ... was founded to create a better method for launching science companies; one that takes ...
(Date:8/15/2019)... ... , ... Serialization deadlines in the US and European Union ... becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing ... most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system capabilities. ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... June 17, 2019 , ... IVERIC bio, ... an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) vector for ... dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 related retinal ...
(Date:6/11/2019)... MONTREAL (PRWEB) , ... June 10, 2019 , ... ... growth of its distribution network with the appointment of Biofeedback Tech Ltd ... physiological monitoring systems are an essential part of many therapeutic treatments and clinical ...
(Date:6/11/2019)... Md. and ROANOKE, Va. (PRWEB) , ... June ... ... care optimized for microlearning engagement, and Carilion Clinic, a national leader in opioid ... the latest in virtual care. , Mytonomy recently deployed its virtual ...
(Date:6/6/2019)... (PRWEB) , ... June 05, 2019 , ... WCCT ... and medical device industries, announced today that they will be receiving 3 awards at ... Diego, CA. WCCT received 2 awards in the categories of overall Quality and Compatibility ...
Breaking Biology Technology:
Cached News: